20 May 2020 – distribution agreement

The company has announced that it has entered into an exclusive distribution agreement with Medusa19 to supply a saliva based rapid test for Covid 19.  The test should give a result within minutes and is designed for use by both healthcare professionals and consumers around the world.  The company’s share price has continued to strengthen and. having tipped the shares at 17.5p in January as one of our Shares of the Year these have now reached acclaimed ten-bagger status!  They are a FIRM HOLD.